Implantica
41 SEK -3,19%1 investor følger denne virksomhed
Implantica is active in medical technology. The company specializes in the development of medical devices. The product portfolio is broad and includes implantable medical instruments, which are further used for the treatment of diseases that affect the esophagus. In addition to the main business, service and related ancillary services are also offered, especially focused on eHealth. Implantica operates worldwide, with the largest presence in North America and Europe.
Omsætning
15,7 mio.
EBIT %
-1.548,94 %
P/E
-
Udbytteafkast, %
-
Kursmål
-
Anbefaling
-
Opdateret
-
First North Stockholm
IMP A SDB
Daglig lav / høj pris
40,8 / 43
SEK
Markedsværdi
48,51 mia. SEK
Aktieomsætning
1,62 mio. SEK
Volumen
39 t
Seneste videoer
Finanskalender
Delårsrapport
15.11.2024
Årsrapport
14.02.2025
Større aktionærerKilde: Millistream Market Data AB
Ejer | Kapital | Stemmer |
---|---|---|
Peter Forsell | 47,4 % | 47,4 % |
Handelsbanken Fonder | 8,6 % | 8,6 % |
EFG Bank | 7,1 % | 7,1 % |
UBP | 2,8 % | 2,8 % |
Avanza Pension | 2,6 % | 2,6 % |
SEB Life | 2,3 % | 2,3 % |
UBS | 2,1 % | 2,1 % |
TIN Fonder | 1,7 % | 1,7 % |
SIX SIS AG | 1,5 % | 1,5 % |
Stephan Siegenthaler | 1,3 % | 1,3 % |
ViserAlle indholdstyper
Implantica announces highly successful 2024 American Foregut Society meeting where RefluxStop® received remarkable pre-launch market feedback
Implantica welcomes 23 top anti-reflux surgeons from 17 leading centers in the first User meeting in Spain, 1.5 years post country launch
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools